Complications of image-guided transcatheter hepatic chemoembolization of primary and secondary tumours of the liver

Anticancer Research

Volumn 30, Issue 12, 2010, Pages 5159-5164

  Poggi, Guido ^a   Pozzi, Emma ^a   Riccardi, Alberto ^a   Tonini, Stefano ^a   Montagna, Benedetta ^a   Quaretti, Pietro ^b   Tagliaferri, Barbara ^a   Sottotetti, Federico ^a   Baiardi, Paola ^a   Pagella, Chiara ^a   Minoia, Claudio ^a   Bernardo, Giovanni ^a  

^a IRCCS   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Arteries; Hepatic chemoembolization; Liver interventional procedures; Liver neoplasm therapy

Indexed keywords

ANTINEOPLASTIC AGENT; DRUG ELUTING MICROSPHERE; EPIRUBICIN; IODINATED POPPYSEED OIL; IRINOTECAN; MICROSPHERE; OXALIPLATIN; UNCLASSIFIED DRUG;

ABDOMINAL AORTA; ACUTE PANCREATITIS; ADULT; AGED; ALLERGIC REACTION; ANEMIA; ANTIBIOTIC PROPHYLAXIS; AORTA DISSECTION; ARTICLE; ARTIFICIAL EMBOLISM; BILE DUCT CARCINOMA; BILOMA; BLEEDING; CHRONIC CHOLECYSTITIS; DIABETES MELLITUS; FALSE ANEURYSM; FEMALE; FEMORAL ARTERY; HUMAN; HYPERTENSIVE CRISIS; LIVER ABSCESS; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER METASTASIS; LIVER TUMOR; MAJOR CLINICAL STUDY; MALE; PAIN; PLEURA EFFUSION; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RISK FACTOR; STENT; THROMBOCYTOPENIA; VARICOSE BLEEDING;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CATHETERIZATION; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 78751474670     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Llovet JM, Real MI, Montana X, Planas R, Coll S, Aponte J, Ayuso C, Sala M, Muchart J, Sola R, Rodes J, Bruix J and Barcelona Liver Cancer Group: Arterial embolization or chemoembolization versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 359: 1734-1739, 2002.
2. Lo CM, Ngan H, Tso WK, Liu CI, Lam CM, Poon RT, Fan ST and Wong J: Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 55: 1164-1171, 2002.
3. Salman HS, Cynamon J, Jagust M, Bakal C, Rozenblit A, Kaleya R, Negassa A and Walder S: Randomized phase II trial of embolization therapy versus chemoembolization therapy in previously treated patients with colorectal carcinoma metastatic to the liver. Clin Colorectal Cancer 2: 173-179, 2002.
4. Abramson RG, Rosen MP, Perry LJ, Brophy DP, Raeburn SL and Stuart KE: Cost-effectiveness of hepatic arterial chemoembolization for colorectal liver metastases refractory to systemic chemotherapy. Radiology 216: 485-491, 2000.
5. Burger I, Hong K, Schulick R, Georgiades C, Thuluvath P, Choti M, Kamel I, Geschwind JF: Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: initial experience in a single institution. J Vase Interv Radiol 16: 353-361, 2005.
6. Poggi G, Amatu A, Montagna B, Quaretti P, Minoia C, Sottani C, Villani L, Tagliaferri B, Sottotetti F, Rossi O, Pozzi E, Zappoli F, Riccardi A and Bernardo G: OEM-TACE: a new therapeutic approach in unresectable intrahepatic cholangiocarcinoma. Cardiovasc Intervent Radiol 32: 1187-1192, 2009.
7. Vogl TJ, Naguib NN, Zangos S, Eichler K, Hedayati A and NourEldin NE: Liver metastases of neuroendocrine carcinomas: interventional treatment via transarterial embolization, chemoembolization and thermal ablation. Eur J Radiol 72: 517-512, 2009.
8. Hong K, Khwaja A, Liapi E, Torbenson MS, Georgiades CS and Geschwind JF: New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer. Clin Cancer Res 12: 2563-2567, 2006.
9. Lewis AL, Taylor RR, Hall B, Gonzalez MV, Willis SL and Stratford PW: Pharmacokinetic and safety study of doxorubicineluting beads in a porcine model of hepatic arterial embolization. J Vase Interv Radiol 17: 1335-1343, 2006.
10. Varela M, Real MI, Burrel M, Forner A, Sala M, Brunet M, Ayuso C, Castells L, Montañá X, Llovet JM and Bruix J: Chemo-embolization of hepatocellular carcinoma with drug-eluting beads: efficacy and doxorubicin pharmacokinetics. J Hepatol 46: 474-481, 2007.
11. Brown DB, Gould JE, Gervais DA, Goldberg SN, Murthy R, Millward SF, Rilling WS, Geschwind JF, Salem R, Vedantham S, Cardella JF and Soulen MC: Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria. J Vasc Interv Radiol 20: S425-434, 2009.
12. Poggi G, Quaretti P, Minoia C, Bernardo G, Bonora MR, Gaggeri R, Ronchi A, Saluzzo CM, Azzaretti A, Rodolico G, Montagna M, Amatu A, Teragni C, Palumbo I, Traverso E, Tonini S, Villani L, Scelsi M, Baiardi P, Felisi MG, Sottotetti F, Tagliaferri B and Riccardi A: Transhepatic arterial chemoembolization with oxaliplatin-eluting microsphere (OEM-TACE) for unresectable hepatic tumors Anticancer Res 25: 3835-3842, 2008.
13. Cancer Therapy Evaluation Program, Common Terminology Criteria for Adverse Events, Version 3.0, DCTD, NCI, NIH, DHHS. March 31, 2003 (http://ctep.cancer.gov), publishing Date: August 9, 2006.
14. Sung Wook Shin: The current practice of transarterial chemoembolization for the treatment of hepatocellular carcinoma. Korean J Radiol 10: 425-434, 2009.
15. Lee HS, Kim JS, Choi IJ, Chung JW, Park JH and Kim CY: The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study. Cancer 79: 2087-2094, 1997.
16. Pentecost MJ, Daniels JR, Teitelbaum GP and Stanley P: Hepatic chemoembolization: safety with portal vein thrombosis. J Vase Interv Radiol 4: 347-351, 1993.
17. Chung JW, Park JH, Han JK, Choi BI, Han MC, Lee HS, Kim CY: Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization. Radiology 195: 33-40, 1996.
18. Sakamoto I, Aso N, Nagaoki K, Matsuoka Y, Uetani M, Ashizawa K, Iwanaga S, Mori M, Morikawa M, Fukuda T, Hayashi K and Matsunaga N: Complications associated with transcatheter arterial embolization for hepatic tumors. Radiographics 18: 605-619, 1998.
19. Song SY, Chung JW, Han JK, Lim HG, Koh YH, Park JH, Lee HS and Kim CY: Liver abscess after transcatheter oily chemoembolization for hepatic tumors: incidence, predisposing factors, and clinical outcome. J Vasc Interv Radiol 12: 313-20, 2001.
20. Geschwind JF, Kaushik S, Ramsey DE, Choti MA, Fishman EK and Kobeiter H: Influence of a new prophylactic antibiotic therapy on the incidence of liver abscesses after chemoembolization treatment of liver tumors. J Vasc Interv Radiol 13: 1163-1166, 2002.
21. Patel S, Tuite CM, Mondschein JI, Soulen MC: Effectiveness of an aggressive antibiotic regimen for chemoembolization in patients with previous biliary intervention. J Vasc Interv Radiol 17: 19311934, 2006.
22. Inoue H, Hori A, Satake M, Kanetsuki I, Ueno K, Nishida H, Ikeda K, Kobayashi H and Nakajo M: Liver abscess formation after treatment of liver cancer by arterial injection using adriamycin/mitomycin C oil suspension (ADMOS). Nippon Igaku Hoshasen Gakkai Zasshi 52: 155-163, 1992.
23. Sakamoto I, Iwanaga S, Nagaoki K, Matsuoka Y, Ashizawa K, Uetani M, Fukuda T, Okimoto T, Okudaira S, Omagari K, Hayashi K and Matsunaga N: Intrahepatic biloma formation (bile duct necrosis) after transcatheter arterial chemoembolization. AJR Am J Roentgenol 181: 79-87, 2003.
24. Wang W, Shi J and Xie WF: Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta-analysis. Liver Int 30: 741-749, 2001.
25. Kagawa T, Koizumi J, Kojima S, Nagata N, Numata M, Watanabe N, Watanabe T, Mine T; Tokai RFA Study Group: Transcatheter arterial chemoembolization plus radiofrequency ablation therapy for early stage hepatocellular carcinoma: comparison with surgical resection. Cancer 116: 3638-3644, 2010.
26. Lammer J, Malagari K, Vogl T, Pilleul F, Denys A, Watkinson A, Pitton M, Sergent G, Pfammatter T, Terraz S, Benhamou Y, Avajon Y, Gruenberger T, Pomoni M, Langenberger H, Schuchmann M, Dumortier J, Mueller C, Chevallier P, Lencioni R; PRECISION V Investigators: Prospective randomized study of doxorubicineluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol 33: 41-52, 2010.
27. Poon RT, Fan ST, Lo CM, Poon RT, Fan ST, Lo CM, Liu CL, Ngan H, Ng IO and Wong J: Hepatocellular carcinoma in the elderly: results of surgical and nonsurgical management. Am J Gastroenterol 94: 2460-2466, 1999.
28. Hazama H, Omagari K, Matsuo I, Masuda J, Ohba K, Sakimura K, Kinoshita H, Isomoto H, Murase K and Kohno S: Clinical features and treatment of hepatocellular carcinoma in eight patients older than eighty years of age. Hepatogastroenterology 48: 1692-1696, 2001.